Replies to post #117288 on Biotech Values

[poorgradstudent]

ONXX:

I figure it's worth pointing out to readers that ONXX appears to be following the path that MLNM did for Velcade. Try to get approval through a single agent trial and have a controlled trial in an earlier setting underway to satisfy the accelerated approval requirements.

It worked quite well for MLNM.